AI
KLRS

Acuitas Investments’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Acuitas Investments’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-46,509
Closed -$865K – 122
2024
Q3 		$865K Buy
46,509
+3,690
+9% +$68.6K 0.39% 86
2024
Q2 		$712K Buy
42,819
+228
+0.5% +$3.79K 0.38% 82
2024
Q1 		$740K Buy
+42,591
New +$740K 0.37% 79